Henri Vranckx
- Pharmaceutical Science top 0.5%
- Biomaterials top 5%
- Molecular Biology
- Materials Chemistry
- Biomedical Engineering
- Co-authors
- Patrick CouvreurD. FanaraKarim AmighiMichel DeleersChristiane DamgéMartín RolandFrancis BrasseurVincent Lenaerts
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (3 papers)Advanced Drug Delivery Systems (3 papers)Crystallization and Solubility Studies (2 papers)
In The Last Decade
Henri Vranckx
8 papers receiving 733 citations
Peers
Comparison fields: 5 of 92
- Pharmaceutical Science 476
- Biomaterials 264
- Molecular Biology 178
- Materials Chemistry 145
- Biomedical Engineering 85
Countries citing papers authored by Henri Vranckx
This map shows the geographic impact of Henri Vranckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Vranckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Vranckx more than expected).
Fields of papers citing papers by Henri Vranckx
This network shows the impact of papers produced by Henri Vranckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Vranckx. The network helps show where Henri Vranckx may publish in the future.
Co-authorship network of co-authors of Henri Vranckx
This figure shows the co-authorship network connecting the top 25 collaborators of Henri Vranckx. A scholar is included among the top collaborators of Henri Vranckx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henri Vranckx. Henri Vranckx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 71 | |
| 2 | 9 | |
| 3 | 289 | |
| 4 | 119 | |
| 5 | 109 | |
| 6 | 81 | |
| 7 | 23 | |
| 8 | 76 |
About Henri Vranckx
Henri Vranckx is a scholar working on Pharmaceutical Science, Dermatology and Biophysics, having authored 8 papers that have together received 777 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Advanced Drug Delivery Systems (3 papers) and Crystallization and Solubility Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (476 citations), Biomaterials (264 citations) and Drug Discovery (1 citation). Henri Vranckx has collaborated with scholars based in Belgium and France. Frequent co-authors include Patrick Couvreur, D. Fanara, Karim Amighi, Michel Deleers, Christiane Damgé, Martín Roland, Francis Brasseur, Vincent Lenaerts, Marie Cecilie Paasche Roland and Arnaud Boutan-Laroze. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.